TrialX Updates: AI Powered Clinical Trial Finder for ALS Network, Taking Decentralized Research Beyond Earth with Ax-4 Space Mission and more…

TrialX AI powered clinical trial finder for ALS Network, ALS Community

We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic lateral sclerosis (ALS) and related motor neuron diseases. The new tool offers a personalized, user-friendly search experience—guiding users through tailored questions, smart filters, and clear trial summaries to help them connect with relevant studies and stay informed through a volunteer registry. ALS is a progressive and fatal neuromuscular condition with no known cure, affecting approximately 5.2 people per 100,000 in the U.S. alone. Learn more.


What’s New at TrialX! 🚀

📢 PRODUCT UPDATES 

Congratulations to the entire team on the successful completion of the Ax-4 mission! In collaboration with the Translational Research Institute for Space Health, we are proud to support this historic mission by enabling critical health data collection to further our understanding of human health and performance in space. Building on our contributions to previous missions like Ax-1 through Ax-3, Fram2, and Inspiration4, we continue pushing the boundaries of decentralized research beyond Earth. With the Ax-4 crew having conducted around 60 scientific studies across 31 countries, we eagerly anticipate the valuable findings that will emerge from this mission. Learn more.


We’re proud to support clinical trial awareness, patient recruitment and engagement efforts for the world’s leading pharmaceutical companies — including powering the clinical trial volunteer registry for a top 3 pharma. Explore how patients are getting connected to trials that matter.


Listen to our CEO, Sharib Khan, discuss real-world strategies for using AI to improve clinical trial accessibility and patient-centricity. In this Q&A session, he explores how AI can help patients discover relevant trials, enable inclusive and precise recruitment, accelerate study materials with generative AI, and shape impactful patient engagement strategies. Watch the full panel discussion to learn more.

🎤️ UNSUNG BUT IMPACTFUL VOICES OF CLINICAL RESEARCH HEROES 

Behind every clinical trial are patients, families, and advocates hoping for answers—and behind them are professionals working to make that journey more informed, accessible, and human. In our blog series – Unsung But Impactful Voices of Clinical Research Heroes – we are talking about the people at the heart of it all. This month we are thrilled to feature Kayleigh Greenwood, Patient Engagement Specialist at The Michael J. Fox Foundation. With a deep commitment to making clinical trials more accessible and patient-friendly, Kayleigh shares her journey, the purpose that drives her, and the moments that continue to inspire her. Read the full interview here.  


RECENT CURETALKS 

We had the privilege of talking to Nobel Laureate Dr. Drew Weissman from The University of Pennsylvania, about the expanding potential of mRNA technology. In this insightful conversation, Dr. Weissman shares how the mRNA platform is being explored to treat celiac disease, cancer, HIV, autoimmune disorders, and neurological and cardiovascular conditions—unlocking a future where medicine is more targeted, responsive, and effective. Watch here.

🧬 FEATURED CLINICAL STUDIES 

Powered by TrialX

The MEMORY Study: Indiana University researchers are studying how daily stress affects memory and thinking in older adults. Participants aged 65+ with memory concerns but no dementia diagnosis, will complete a memory assessment, track stress for two weeks using a phone and smartwatch, and return for follow-ups one and two years later.


Neurostimulation for Binge Eating: An early feasibility pilot study at Penn Medicine is investigating the safety and functionality of the NeuroPace RNS® System—a responsive brain-stimulation device—for adults aged 22–70 with obesity and frequent loss-of-control eating despite prior treatments. 


The ASPIRION Study: This study is testing a new drug to help people with celiac disease who still have symptoms even on a gluten-free diet. Participants, between age 18–75, will receive the study drug or a placebo through regular injections while continuing their current diet. The study lasts up to 48 weeks, with a chance to continue longer.


Training the Brain for Healthy Vision: Researchers are studying how the brain adapts after central vision loss, using simulations in healthy adults aged 18–30. The goal is to improve future therapies for conditions like macular degeneration by understanding how different types of visual training affect perception and brain function. 


🌎 AROUND THE WEB  

💉 Implant alert: A new diabetes device warns users before blood sugar drops dangerously.
🧪 AI in the lab: Isomorphic Labs gears up for clinical trials of AI-designed drugs.
🚀 ChatGPT copilots? Early tests show it can fly spacecraft surprisingly well.
🤖 Hallucination hazard: Experts warn about the real-world risks of AI errors in healthcare.


‼️ NOTEWORTHY 


🤝 TEAM UPDATES  

🎵 Create a personalized song to honor a clinical research hero—patient, coordinator, researcher, or caregiver—on Songs for the Unsung by TrialX. It takes just a minute to craft a tribute they’ll never forget. Share their song on LinkedIn, tag them (and us!), and let’s amplify their impact through music. 👉 Create your song here.


🧑‍💻️ WE ARE HIRING!

At TrialX, we obsess over outcomes that improve patients’ lives and sponsors’ success. We are hiring a Product Manager – Clinical Trial Recruitment Platform (Enterprise SaaS) for our NY/NJ/PA  office. Email your resume and a short note about how you would elevate AI‑powered patient recruitment and engagement to jobs@trialx.com. Join TrialX and build products that embody excellence and push the boundaries of what’s possible—while learning for life. Learn More.

At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
8

Get in touch to learn more about TrialX's Remote Data Collection Solutions

Request a Demo
29275

Shweta Mishra

Shweta is Marketing and Communications Lead at TrialX/Applied Informatics. She is a clinical trials enthusiast and also hosts women's health/infertility/reproductive medicine talk series driven by her personal experiences for TrialX CureTalks. A San Jose State University Graduate, she holds dual masters degree in Biochemistry and Nutrition Science, and is passionate about the science behind the diverse life phenomenon. She also holds certifications in Marketing Management & Strategy, Digital Marketing from Hubspot Academy, Protecting Human Research Participants from NIH and in Intellectual Property in Biotechnology from WIPO.